CIK 0001813814 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Definium Therapeutics, Inc.
Sign in to watch- Ticker
- DFTX
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- 212-220-6633
- Business address
- ONE WORLD TRADE CENTER, SUITE 8500, NEW YORK, NY, 10007
- Former names
- Mind Medicine (MindMed) Inc.
- 4 Open-market sale Chief Medical Officer sold 6,774 shares at $3.63 ($24,590)
- 4 Open-market sale Chief Executive Officer sold 13,237 shares at $3.63 ($48,050)
- 4 Open-market sale Chief Financial Officer sold 5,652 shares at $3.63 ($20,517)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Regulation FD disclosure · Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Open-market sale Chief Executive Officer sold 13,499 shares at an average $3.58 ($48,274)
- 4 Open-market sale Chief Medical Officer sold 6,918 shares at an average $3.57 ($24,730)
- 4 Open-market sale Chief Financial Officer sold 5,762 shares at an average $3.58 ($20,609)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K/A Event Other events
- 8-K/A Event Other events
- 4 Open-market sale Chief Financial Officer sold 20,000 shares at $3.80 ($76,000)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 13 of 26 · 506 filings